{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02a634-2021-04-15T10:22:41+01:00",
    "date": "2021-04-15T10:22:41+01:00",
    "ocid": "ocds-h6vhtk-02a634",
    "initiationType": "tender",
    "tender": {
        "id": "DN535566",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Purchase of AAA Netspot - Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33000000",
            "description": "Medical equipments, pharmaceuticals and personal care products"
        },
        "mainProcurementCategory": "goods",
        "description": "AAA Netspot is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours",
        "lots": [
            {
                "id": "1",
                "description": "The Royal Marsden Hospital NHS Foundation Trust needs to purchase AAA Netspot vials which is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours",
                "hasOptions": false
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKI"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_OUTSIDE_SCOPE",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "procurementMethodRationale": "AAA Netspot vials is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours. A radioactive diagnostic agent for positron emission tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected somatostatin receptor positive neuroendocrine tumors (NETs) for localizing primary tumours and their metastases. This innovative technology supports a more accurate diagnosis and staging of NETs and a more tailored treatment plan"
    },
    "awards": [
        {
            "id": "007875-2021-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-12423",
                    "name": "Advance Accelerator Applications"
                },
                {
                    "id": "GB-FTS-12424",
                    "name": "Advance Accelerator Applications"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-12422",
            "name": "The Royal Marsden NHS Foundation Trusts",
            "identifier": {
                "legalName": "The Royal Marsden NHS Foundation Trusts"
            },
            "address": {
                "streetAddress": "Harbour Yard",
                "locality": "London",
                "region": "UKI",
                "postalCode": "SW10 0XD",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "chelwest.tenders@nhs.net",
                "email": "chelwest.tenders@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.royalmarsden.nhs.uk",
                "buyerProfile": "https://www.royalmarsden.nhs.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-12423",
            "name": "Advance Accelerator Applications",
            "identifier": {
                "legalName": "Advance Accelerator Applications"
            },
            "address": {
                "locality": "London",
                "region": "UKI",
                "postalCode": "NW1 5QT",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-12424",
            "name": "Advance Accelerator Applications",
            "identifier": {
                "legalName": "Advance Accelerator Applications"
            },
            "address": {
                "locality": "London",
                "region": "UKI",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-525",
            "name": "High Court",
            "identifier": {
                "legalName": "High Court"
            },
            "address": {
                "locality": "London",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-12422",
        "name": "The Royal Marsden NHS Foundation Trusts"
    },
    "contracts": [
        {
            "id": "007875-2021-1",
            "awardID": "007875-2021-1",
            "status": "active",
            "value": {
                "amount": 475200,
                "currency": "GBP"
            },
            "dateSigned": "2021-04-07T00:00:00+01:00"
        }
    ],
    "language": "en"
}